Tracy Walker, RN, BSN, CCRP
Research Nurse
OHSU Knight Cancer Institute
503-346-1183
Exercise Questions to Keep in Mind
•
Is there an adverse event?
•
What is the severity?
•
What is the relationship to study drug?
•
Is it a serious adverse event?
•
Is it an unanticipated problem?
•
Does it need to be reported?
•
To whom do you report?
Safety Reporting Definitions
•
Serious adverse experience (21CFR312.32)
–
Any adverse experience occurring at any dose that results in any
of the following outcomes:
•
death
•
life-threatening adverse experience
•
in-patient hospitalization or prolongation of existing
hospitalization
•
persistent or significant disability/incapacity
•
congenital anomaly/birth defect
Unanticipated Problems – Remember: ‘Must fit all’
1. On Protocol 2. SAE 3. Unanticipated 4. Related or Possibly Related Category 1 1. On Protocol 2. Anticipated AE or SAE 3. Related or Possibly Related 4. Occurring at a higher frequency or severity Category 2 1. Unanticipated AE or SAE 2. Related or Possibly Related 3. May alter the risks and therefore warrants changes to the protocol, DSMP, or consent process Category 3 1. Unanticipated 2. ‘Other’ events 3. May place subjects or others at greater risk of harm or discomfort. Harm need not have occurred. Category4
A Phase II Trial of the Safety and Efficacy of
Abc-001 for the Treatment of CoordinatorStressitis
2 yr trial
Abc-001 50 mg tablet daily PO
30 subjects
Age > 18 years
Dx: occupation in research
9/29/201 4
Investigator’s Brochure
Drug:
Abc-001
Serious reactions
•
Death
•
Respiratory distress
•
Severe neutropenia
•
Hepatitis
•
Excessive bleeding
Common side effects
•
Nausea
•
Vomiting
•
Diarrhea
•
Abdominal pain
•
Abnormal LFT’s
•
Rash
•
Low K+
•
Elevated QTc
•
Headaches
History for Subject 507
•
41 year old female otherwise in good general health
•
Diagnosis of occupation in research
•
Medical hx: asthma, allergies
•
Complains of intermittent, mild headaches
•
No known drug allergies
Physical for Subject 507
•
Alert, oriented, NAD
•
Normal physical exam
•
BP 110/70, HR 76
Progress Note
1/3/10 Subject 507 in for study visit. Reports feeling her
usual self. Takes study drug regularly. No side
effects reported. No change in concomitant
medications.
Subject Diary
1/10/10 Anxiety attack had to miss work. Felt nervous
all day.
1/12/10 Feeling better.
Back at work.
Exercise Questions to Keep in Mind
•
Is there an adverse event?
•
What is the severity?
•
What is the relationship to study drug?
•
Is it a serious adverse event?
•
Is it an unanticipated problem?
•
Does it need to be reported?
•
To whom do you report?
Unanticipated Problems – Remember: ‘Must fit all’
1. On Protocol 2. SAE 3. Unanticipated 4. Related or Possibly Related Category 1 1. On Protocol 2. Anticipated AE or SAE 3. Related or Possibly Related 4. Occurring at a higher frequency or severity Category 2 1. Unanticipated AE or SAE 2. Related or Possibly Related 3. May alter the risks and therefore warrants changes to the protocol, DSMP, or consent process Category 3 1. Unanticipated 2. ‘Other’ events 3. May place subjects or others at greater risk of harm or discomfort. Harm need not have occurred. Category4
Progress Note
1/22/10 Subject 507 in for study visit. Reports nausea
lasting 2 hours on 1/18/10.
9/29/201 4
Investigator’s Brochure
Drug:
Abc-001
Serious reactions
•
Death
•
Respiratory distress
•
Severe neutropenia
•
Hepatitis
•
Excessive bleeding
Common side effects
•
Nausea
•
Vomiting
•
Diarrhea
•
Abdominal pain
•
Abnormal LFT’s
•
Rash
•
Low K+
•
Elevated QTc
•
Headaches
Exercise Questions to Keep in Mind
•
Is there an adverse event?
•
What is the severity?
•
What is the relationship to study drug?
•
Is it a serious adverse event?
•
Is it an unanticipated problem?
•
Does it need to be reported?
•
To whom do you report?
Unanticipated Problems – Remember: ‘Must fit all’
1. On Protocol 2. SAE 3. Unanticipated 4. Related or Possibly Related Category 1 1. On Protocol 2. Anticipated AE or SAE 3. Related or Possibly Related 4. Occurring at a higher frequency or severity Category 2 1. Unanticipated AE or SAE 2. Related or Possibly Related 3. May alter the risks and therefore warrants changes to the protocol, DSMP, or consent process Category 3 1. Unanticipated 2. ‘Other’ events 3. May place subjects or others at greater risk of harm or discomfort. Harm need not have occurred. Category4
1/27/10 Reports fractured ankle from falling off a horse.
Outpatient surgical repair with excessive bleeding that
required overnight hospitalization. Study drug held for 2
weeks. Vicodin added to concomitant medications.
9/29/201 4
Investigator’s Brochure
Drug:
Abc-001
Serious reactions
•
Death
•
Respiratory distress
•
Severe neutropenia
•
Hepatitis
•
Excessive bleeding
Common side effects
•
Nausea
•
Vomiting
•
Diarrhea
•
Abdominal pain
•
Abnormal LFT’s
•
Rash
•
Low K+
•
Elevated QTc
•
Headaches
Exercise Questions to Keep in Mind
•
Is there an adverse event?
•
What is the severity?
•
What is the relationship to study drug?
•
Is it a serious adverse event?
•
Is it an unanticipated problem?
•
Does it need to be reported?
•
To whom do you report?
Unanticipated Problems – Remember: ‘Must fit all’
1. On Protocol 2. SAE 3. Unanticipated 4. Related or Possibly Related Category 1 1. On Protocol 2. Anticipated AE or SAE 3. Related or Possibly Related 4. Occurring at a higher frequency or severity Category 2 1. Unanticipated AE or SAE 2. Related or Possibly Related 3. May alter the risks and therefore warrants changes to the protocol, DSMP, or consent process Category 3 1. Unanticipated 2. ‘Other’ events 3. May place subjects or others at greater risk of harm or discomfort. Harm need not have occurred. Category4
Progress Note
2/2/10 Subject 507 in for study visit. Reports recovering
from ankle fracture. Complains of increased headaches.
Doubled her use of ibuprofen, continues pain medication
and no change in other meds. Headaches are so severe,
subject could not go to work.
9/29/201 4
Investigator’s Brochure
Drug:
Abc-001
Serious reactions
•
Death
•
Respiratory distress
•
Severe neutropenia
•
Hepatitis
•
Excessive bleeding
Common side effects
•
Nausea
•
Vomiting
•
Diarrhea
•
Abdominal pain
•
Abnormal LFT’s
•
Rash
•
Low K+
•
Elevated QTc
•
Headaches
Unanticipated Problems – Remember: ‘Must fit all’
1. On Protocol 2. SAE 3. Unanticipated 4. Related or Possibly Related Category 1 1. On Protocol 2. Anticipated AE or SAE 3. Related or Possibly Related 4. Occurring at a higher frequency or severity Category 2 1. Unanticipated AE or SAE 2. Related or Possibly Related 3. May alter the risks and therefore warrants changes to the protocol, DSMP, or consent process Category 3 1. Unanticipated 2. ‘Other’ events 3. May place subjects or others at greater risk of harm or discomfort. Harm need not have occurred. Category4
Progress Note
2/15/10 Subject 507 in for study visit. Reports cold
symptoms of runny nose and non-productive cough. Took
cold remedies for 2 days. Does not recall the medication
names, doses or dates taken.
Plan: Review the importance of keeping track of dates and
any concomitant medications while participating in a study.
9/29/201 4
Investigator’s Brochure
Drug:
Abc-001
Serious reactions
•
Death
•
Respiratory distress
•
Severe neutropenia
•
Hepatitis
•
Excessive bleeding
Common side effects
•
Nausea
•
Vomiting
•
Diarrhea
•
Abdominal pain
•
Abnormal LFT’s
•
Rash
•
Low K+
•
Elevated QTc
•
Headaches
•
2/20/10 Someone broke into your car and stole a few
items … including the laptop on which you keep data
for this study.
Unanticipated Problems – Remember: ‘Must fit all’
1. On Protocol 2. SAE 3. Unanticipated 4. Related or Possibly Related Category 1 1. On Protocol 2. Anticipated AE or SAE 3. Related or Possibly Related 4. Occurring at a higher frequency or severity Category 2 1. Unanticipated AE or SAE 2. Related or Possibly Related 3. May alter the risks and therefore warrants changes to the protocol, DSMP, or consent process Category 3 1. Unanticipated 2. ‘Other’ events 3. May place subjects or others at greater risk of harm or discomfort. Harm need not have occurred. Category4
Progress
Note
3/3/10 Subject 507 in for study visit.
Reports stomach ache about 30 minutes
after taking study drug. Lasts 1 hour,
does not require medication or interfere
with her usual activity.
Progress Note
3/15/10 Subject 507 in for study visit. Reports rapid
onset of intermittent blurred vision beginning 3/9/10
and lasting 3 days. Reports no other problems.
Continues study drug and no change in concomitant
medications.
9/29/201 4
Investigator’s Brochure
Drug:
Abc-001
Serious reactions
•
Death
•
Respiratory distress
•
Severe neutropenia
•
Hepatitis
•
Excessive bleeding
Common side effects
•
Nausea
•
Vomiting
•
Diarrhea
•
Abdominal pain
•
Abnormal LFT’s
•
Rash
•
Low K+
•
Elevated QTc
•
Headaches
Unanticipated Problems – Remember: ‘Must fit all’
1. On Protocol 2. SAE 3. Unanticipated 4. Related or Possibly Related Category 1 1. On Protocol 2. Anticipated AE or SAE 3. Related or Possibly Related 4. Occurring at a higher frequency or severity Category 2 1. Unanticipated AE or SAE 2. Related or Possibly Related 3. May alter the risks and therefore warrants changes to the protocol, DSMP, or consent process Category 3 1. Unanticipated 2. ‘Other’ events 3. May place subjects or others at greater risk of harm or discomfort. Harm need not have occurred. Category4
Progress Note
4/15/10 Subject reports having horrible nightmares.
According to her spouse, she is sleep walking and
has become a danger to herself.
Subject is admitted to the sleep unit for overnight
observation.
9/29/201 4
Investigator’s
Brochure
Drug:
Abc-001
Serious reactions
•
Death
•
Respiratory distress
•
Severe neutropenia
•
Hepatitis
•
Excessive bleeding
Common side effects
•
Nausea
•
Vomiting
•
Diarrhea
•
Abdominal pain
•
Abnormal LFT’s
•
Rash
•
Low K+
•
Elevated QTc
•
Headaches
Unanticipated Problems – Remember: ‘Must fit all’
1. On Protocol 2. SAE 3. Unanticipated 4. Related or Possibly Related Category 1 1. On Protocol 2. Anticipated AE or SAE 3. Related or Possibly Related 4. Occurring at a higher frequency or severity Category 2 1. Unanticipated AE or SAE 2. Related or Possibly Related 3. May alter the risks and therefore warrants changes to the protocol, DSMP, or consent process Category 3 1. Unanticipated 2. ‘Other’ events 3. May place subjects or others at greater risk of harm or discomfort. Harm need not have occurred. Category4